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Background. The psychiatric disorders like anxiety and depression could have a profound influence on onset, expression, and
course of Irritable bowel syndrome (IBS). Aim. To estimate the frequency and strength of association of common mental disorders
(CMDs) in patients with IBS and patients with other chronic diseases, that is, migraine and hypertension. Method. This was a
case control study. Individuals aged 18–70 years diagnosed as IBS were enrolled as cases. The control groups consisted of patients
without IBS but diagnosed to have a chronic disease, that is, migraine or HTN. Self-Reporting Questonnaire-20(SRQ-20) was used
as a screening tool for the detection of CMD. Results. 82 patients were enrolled in each group. Mean SRQ score was significantly
higher in IBS group than controls (9.9 ± 4.5 versus 4.9 ± 3.6, P < 0.001). CMDs were more frequent (67.1% versus 22%) and the
odds of CMD were 7.24 times higher among IBS patients than controls (95% CI 3.6–14.5, P < 0.001). No diﬀerence was found in
frequency of CMDs among various subtypes of IBS. Conclusion. We found that CMDs are more common and strongly associated
with IBS as compared to other chronic diseases. Early screening for CMDs might be useful for an eﬀective management of IBS.

1. Introduction
Irritable bowel syndrome (IBS) is a common health problem which not only aﬀects 10–20% of adult population
worldwide [1] but also account for up to 25% outpatient
workload of a gastroenterologist [2–4]. IBS is considered
as a functional bowel disorder characterized by abdominal
pain/discomfort which is relieved by defecation and associated with altered stool frequency and/or consistency, in
the absence of structural, microbiological, and biochemical
abnormalities [3, 5, 6]. The overall point prevalence of IBS
in Asia varies from 4.4% to 10.4% in various communities
[3, 7]. The exact prevalence of IBS in Pakistani population is
unknown. However, the prevalence of IBS was found 34% in
a study conducted in 508 college going students of Karachi,
Pakistan [7]. Likewise, 45% of 1048 adults living in Karachi
and Bahawalpur were found to be aﬀected by IBS [8].
Despite conceptualization of several mechanisms, the
exact cause of IBS remains uncertain. Currently, postulated

mechanisms include exaggerated visceral hypersensitivity,
gastrointestinal motor disturbances, and postinfectious IBS
[5]. In addition, the brain gut axis has been suggested.
Studies from diﬀerent parts of the world have revealed
underlying psychiatric disorders in 40–60% of IBS cases
which is significantly higher than healthy control or controls
with other chronic diseases [5, 9–15]. Moreover, in a study
conducted in our hospital significantly high proportion
of patients with functional dyspepsia were found to have
common mental disorders as compared to controls (71.33%
versus 15.33%, P < 0.001) [16]. Hence, the proper screening
and management of associated common mental disorders in
addition to the treatment is needed.
Common mental disorders (CMD) described as anxiety,
depression, and somatoform disorders are the most frequent
and disabling group of psychiatric states [17]. These CMDs
like depression not only aﬀect the quality of life but may
potentially increase short-term mortality in cardiac patients
[18]. Significant depressive symptoms have been reported in
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patients aﬀected by chronic illness [19] for example, 18%
of patients with migraine was found aﬀected by CMD [20]
and almost 50% patients with depression was found to have
hypertension (HTN) [21]. In Pakistan, the overall reported
prevalence of anxiety and depressive disorders is 34%, which
is yet another challenge for a resource poor country like
Pakistan [22].
Individuals with IBS incur more direct health care costs
than non-IBS patients, particularly for their nongastrointestinal complaints including psychiatric symptoms [9, 23].
Frequency of symptoms experienced, concern of serious
underlying illness, lower quality of life, and coexisting health
problems lead to frequent visits and extended investigations
of IBS patients [2]. Furthermore, coexisting CMD with IBS
may further deteriorate health resulting in absenteeism at
work, increased health care cost thus has significant implications on economics for a poor country like Pakistan. To
date there is no published data regarding frequency of CMD
in patients with IBS from Pakistan. Hence, identification of
associated psychiatric disorders may help in treatment and
counseling of patients with IBS through early psychological
or psychopharmacological interventions [6]. Therefore, it is
imperative to know the frequency and strength of association
of CMD in patients with IBS from our region.
Thus, the current study is designed to estimate the
frequency and strength of association of common mental
disorders (CMDs) in Pakistani patients with irritable bowel
syndrome (IBS) and patients with other chronic diseases,
that are, migraine and hypertension. It is hypothesized that
among IBS cases the CMD is greater than controls.

2. Methods
2.1. Study Design and Setting. Two parallel case control studies [16] were conducted in 2009 in Gastroenterology clinics
of The Aga Khan University Hospital (AKUH), Karachi,
Pakistan. First was the current study designed to evaluate
the frequency of CMDs in patients with IBS as compared
to controls. The AKUH is a tertiary care hospital where
patients are referred from all over the country for treatment.
The current study was conducted in outpatient Gastroenterology and Neurology clinics from January–September
2009. Individuals aged 18–70 years who could read and
understand Urdu (national language) or English were oﬀered
to participate. Those who agreed to participate and met the
eligibility criteria were enrolled with their consent.
2.2. Selection of Cases and Controls. Individuals visiting our
Gastroenterology clinics and already diagnosed to have IBS
by a qualified gastroenterologist at AKUH were recruited
randomly as “cases”. However, those cases of IBS with diagnosed psychiatric disorders including CMD, other concomitant chronic diseases including HTN, DM, ischemic heart
disease, and migraine, or had limited functional activity (i.e.,
functional class ≥2) were excluded. Diagnosis of IBS was
made according to Room III criteria for IBS. Rome III criteria
have been found useful and cost eﬀective for diagnosing IBS
in clinical practice, epidemiological surveys, physiological
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research and therapeutic trials [1, 6, 13]. Moreover, the IBS
cases were also categorized into subtypes, that are, (1) IBS
with constipation (IBS-C), (2) IBS with diarrhea (IBS-D),
and (3) Mixed IBS (IBS-M) [1].
The control group was randomly selected from Neurology and Medicine clinics of AKUH. The control group
comprised of patients who either have migraine diagnosed by
a qualified neurologist or have HTN diagnosed based upon
the Seventh Report of Joint National Committee (JNC VII)
on Prevention, Detection, Evaluation, and Treatment of high
blood pressure [24]. According to JNC VII Hypertension
was defined as a mean of two or more properly measured
seated BP readings of systolic BP ≥ 140–159 mmHg or
diastolic BP ≥ 90–99 mmHg on each of two or more oﬃce
visits [24]. Migraine was defined as lateralized, throbbing,
or dull episodic headache occurring without preceding
aura, sometimes associated with anorexia, nausea, vomiting,
cognitive impairment, and blurring of vision [25].
Common mental disorders (CMD) describe the state
of anxiety, depression, and psychosomatic disorders [17].
Based upon DSM IV criteria, diagnosis of major depression
was made if an individual experienced five or more of the
following symptoms for at least two consecutive weeks; (1)
depressed mood, (2) loss of interest or pleasure in most or
all activities, (3) insomnia or hypersomnia, (4) change in
appetite or weight, (5) psychomotor retardation or agitation,
(6) low energy, (7) poor concentration, (8) thoughts of
worthlessness or guilt, and (9) recurrent thoughts about
death or suicide. However, the individual diagnosed to
have minor depression if experiences any two or four of
the nine symptoms of major depression present most of
the day, nearly every day, for at least two weeks, at least
one being depressed mood or loss of interest/pleasure [26].
Anxiety disorder defined as an uncontrollable disposition
to worry about one’s welfare and that of one’s immediate
kin associated with wide range of physical and aﬀective
symptoms, changes in behavior, and cognition like arousal,
vigilance, tension, irritability, and unrestful sleep [26, 27].
2.3. Screening for Common Mental Disorders. We used selfreporting questionnaire-20 (SRQ-20) which is one of the
most widely used self-administered psychiatric questionnaires developed by Harding et al. [28] for World Health
organization (WHO) to screen for CMD, especially in
developing countries. It is available in at least 21 language
translations including a validated Urdu version [29–32]. It
has not only been validated but also adapted for crosscultural use in Pakistan [30]. It is simple, easy to interpret
and takes only few minutes to administer the questionnaire
[30, 31, 33–36]. It consists of 20 questions and inquires about
the presence of symptoms over the period of last 30 days [36].
Each item is scored 0 or 1. A score of 1 indicates the presence
and 0 indicates the absence of symptoms with a maximum
score of 20. Diﬀerent cut oﬀ for SRQ scores has been used in
diﬀerent studies. However, a cutoﬀ point of 8/9 (8 “yes” for a
“control” and 9 “yes” for a “case”) is common with sensitivity
of about 80% and specificity of 75% [30, 31].
Thus, eligible patients were interviewed by a single interviewer to screen them for CMDs by using SRQ-20. Moreover,
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Table 1: Comparison among patients with IBS and controls.
Controls mean ± SD or n (%)
39.9 ± 11.2

61 (74.4)
21 (25.6)
9.9 ± 4.5

48 (58.5)
34 (41.5)
4.9 ± 3.6

55 (67.1)
27 (32.9)

18 (22.0)
64 (78.0)

information regarding age, gender, marital status for cases
and controls, and type of IBS for cases were also collected.
This was a prospective, case control study, conducted
by maintain compliance with the Helsinki Declaration. This
was an interview based study and study participants were
interviewed after their informed consent and there was no
intervention involved.
2.4. Statistical Analysis. Sample size was calculated by using
EPI Info version 6 [37]. Assuming the prevalence of CMDs
40% in IBS group [11] and 18% in the control group
[19, 20] we require 148 (74 individuals in each group) to
detect a diﬀerence in the proportion of CMDs in IBS group
versus control group with 80% power, at 5% significance
level. Adding 10% refusals to the calculated sample size, we
required target sample size of 164 (82 subjects in each arm).
Data was analyzed in SPSS version 16.0. Mean ± standard
deviation were calculated for quantitative variables (age,
SRQ score) and proportions (percentage) were calculated
for categorical data (gender, subtypes of IBS). The baseline
characteristics were compared in the two groups by using
independent student t-test for continuous variable and chisquare or Fisher exact test for categorical variables wherever
appropriate. The association of age with CMDs was checked
by stratifying cases and controls on age. A P value < 0.05 was
considered statistically significant. All P values were single
sided. Furthermore, binary logistic was performed to see
association between CMDs and subtypes of IBS.

3. Results
A total of 164 patients; 82 patients in each group were
enrolled. Out of 82 patients in control group, 42 patients had
HTN and 40 had migraine. In IBS group, the proportion
of IBS-constipation, IBS-diarrhea, and IBS-mixed were 37
(45.1%), 29 (35.4%), and 16 (19.5%), respectively. No
diﬀerence was observed in mean age among patients with IBS
and controls (43.1 ± 12.1 versus 39.9 ± 11.2 years, 95% CI
0.9–1.0, P = 0.08). There was male predominance in both
groups. Moreover, CMDs were more frequent among males
aﬀected by IBS than controls (74.4% versus 58.5%, 95% CI
0.3–0.9, P = 0.03) (Table 1).
Overall mean SRQ score was 7.4 ± 4.7 (range 0–18).
Mean SRQ score was significantly higher in IBS group as
compared to the control group (9.9 ± 4.5 versus 4.9 ±

95% confidence interval
0.95–1.00

P value
0.08

0.25–0.94

0.03

1.22–1.44

<0.001

3.6–14.5

<0.001

12

10

8
Number of cases

Age (years)
Gender
Male
Females
SRQ score
CMDs
Present
Absent

Cases mean ± SD or n (%)
43.1 ± 12.1

6

4

2

0
0

2

4

6

8
10
SRQ scores

12

14

16

18

Subjects
Control group
IBS group

Figure 1: Comparison of SRQ-scores in IBS patients and controls.

3.6, 95% CI 1.22–1.44, P < 0.001) (Figure 1). Using the
cut oﬀ 8/9 for SRQ score, common mental disorders were
found in 55 (67.1%) of patients with IBS as compared
to 18 (22%) of the control group. Moreover, the odds to
be aﬀected by CMDs were 7.2 times greater among IBS
cases as compared to the control group (95% CI 3.6–14.5,
P < 0.001). Furthermore, no diﬀerence was observed in
frequency of CMDs among IBS cases and controls when both
study groups were stratified on age (P value 0.6).
Binary logistic was also performed to see an association
of CMD with subtypes of IBS. No diﬀerence was found in
distribution of age and gender among diﬀerent subtypes
of IBS. Mean SRQ score was 10.62 ± 4.56, 8.52 ± 4.52,
and 10.13 ± 4.12 in IBS-C, IBS-D, and IBS-mixed group,
respectively (P = 0.16). Likewise, no diﬀerence was observed
in frequency of CMD among patients with IBS-C, IBS-D, and
IBS-mixed (27 (73.0%) versus 16 (55.2%) versus 12 (75.0%),
P = 0.23) (Table 2).
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Table 2: Baseline demographic characteristics and CMD status of patients with diﬀerent subtypes of IBS.
IBS-C

IBS-D

IBS-mixed

25 (67.56%)
12 (32.4%)
38.3 ± 10.13

21 (72.4%)
8 (27.6%)
42.6 ± 13.05

15 (93.8%)
1 (6.3%)
38.7 ± 9.67

14 (37.8%)
8 (21.6%)
12 (32.4%)
3 (8.1%)
10.62 ± 4.56
27 (73.0%)

8 (27.6%)
9 (31.0%)
5 (17.2%)
7 (24.1%)
8.52 ± 4.52
16 (55.2%)

6 (37.5%)
5 (31.3%)
4 (25.0%)
1 (6.3%)
10.13 ± 4.12
12 (75.0%)

P value

∗

Gender
Male
Female
Age (years)†
Age categories (years)∗
18–34
35–40
41–50
51–67
SRQ score†
CMD present∗
∗

0.12
0.26

0.36

0.16
0.23

n (%), † mean ± SD.

4. Discussion
In this case control study, the distribution of age was
comparable in both IBS and with chronic disease. Males
were predominant among both cases and controls; however,
the proportion of females was significantly higher in control
group as compared to IBS group. Mean SRQ score and
frequency of CMD were significantly higher in IBS group
as compared to controls. We did not find diﬀerence in
proportion of CMD and mean SRQ score among patients
with IBS-C, IBS-D, and IBS-mixed. However, these findings
were based upon post-hoc analysis and could be due to
insuﬃcient small sample size to assess this association.
The implications of our study are that there was a
male predominance in both groups and CMDs were more
frequent among male cases than controls. These findings
are consistent with local studies conducted by Jafri and
colleagues where IBS was found predominantly in males that
is, 56% [8] and 48% (versus 42% in females) [7], respectively.
Moreover, Healthcare seekers among IBS patients were
predominantly males than females (56% versus 44%) [8].
Likewise, studies from neighboring country India have
reported higher rates of IBS and dyspepsia among males
than females [38, 39]. This might be due to possibility of
male patients consulting doctors more often than females
due to various sociocultural reasons here. Hence, in our
study finding IBS more in males may suggest that the male
preponderance for IBS is not a chance finding.
Our findings are consistent with Trikas and colleagues
[10], who found depressive disorders more common among
patients with IBS as compared to controls aﬀected by cholelithiasis (36.1% versus 7.1%, P = 0.016). Likewise, 40
patients with IBS were compared with 32 patients with
inflammatory bowel disease (IBD) and 34 healthy controls
[40]. Prevalence of anxiety, depressive, and mood disorders
as well as higher scores on anxiety and depression scales were
found in IBS group as compared to the controls. Moreover,
these findings were also true for patients with IBD as compared to healthy controls. In our study, the risk of CMD
among patients with IBS was found 7.2 times higher than
the controls. Moreover, we have used SRQ-20 to screen CMD

in our study which is not only sensitive to detect depressive disorders but also detects anxiety and other somatoform disorders as well [19, 20]. However, conflicting results
have also been reported in some studies.
In a cohort of 1037 young individuals in Dunedin, New
Zealand [9], relationship between psychiatric disorders and
IBS was investigated. Rome II and Manning criteria for
IBS and modified version of Diagnostic interview Schedule
was used to detect psychiatric disorders. No association was
found between IBS and psychiatric disorders in this cohort.
In contrast to this study where only young individuals of
age 26 years were evaluated, individuals with age 18–70
years were evaluated in our study which may be a possible
explanation for diﬀerence in frequencies of CMD in IBS.
Another explanation may be that the first occurrence of IBS
mostly occurs between 30–50 years of age [13]. Hence, the
population under study represents a broad sample.
The limitations of our study include screening for CMD
was based upon SRQ-20. It consists of symptoms experienced during last four weeks that could have led to some
degree of recall bias. We found it better not match our cases
and controls for age and gender. As age and gender are
known risk factors for IBS and CMDs [5]. Moreover, prior
local and regional studies had reported male preponderance
for IBS. In case of matching for age and gender, association
of age and gender could not be studied.
It has been suggested that cross-cultural research regarding molecular biology, genetic and psychosocial factors, disease manifestations, diagnosis and treatment, health seeking
behaviors, health-related quality of life, all aspects of IBS
could be aﬀected by culture, and ethnicity and race. Hence,
well-designed cross-cultural studies can help us to understand the epidemiology, pathophysiological mechanisms,
and therapeutic interventions related to IBS [41, 42]. Pakistan is a developing country where political and economic
instability is a major concern. Data from population-based
studies indicate that a one-third of Pakistan’s population has
anxiety and depression [19, 39]. Despite the high burden of
psychological problems, mental health is not given a priority
in the National Health Policy and only 0.4% of health care
budget is being allocated to mental health [43]. Although
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cost-eﬀective treatments exist for these disorders, required
trained mental-health professionals are not available to deal
with them. Public funded primary health care is ineﬀective
and underresourced.

5. Conclusion
We found that CMDs is more common and strongly associated with IBS as compared to other chronic diseases including
migraine and HTN. Hence, early screening for CMDs in IBS
patients might be useful for an eﬀective management of IBS.
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